S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Avoro Capital Advisors/Q3 2021

Avoro Capital Advisors

Period: Q3 2021 Β· Filed: 2021-11-15
View on SEC EDGAR β†—
AUM
$6.37B
Total portfolio value
Positions
47
Reported securities
Top Holding
HZNP
15.5% $985.9M
QoQ Changes
+6 / -7
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2021-11-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
HZNPHORIZON THERAPEUTICS PLC$985.9M15.49%β€”β€”
15.5%
MRTXMIRATI THERAPEUTICS INC$884.5M13.89%β€”β€”
13.9%
XLRNACCELERON PHARMA INC$688.4M10.81%β€”β€”
10.8%
UTHRUNITED THERAPEUTICS CORP$553.7M8.70%$184.58$555.91+201.2%
8.7%
ASNDASCENDIS PHARMA$315.6M4.96%$159.39$274.50+72.2%
5.0%
ARGXARGENX SE$285.8M4.49%$302.00$939.68+211.2%
4.5%
SRPTSAREPTA THERAPEUTICS INC$231.2M3.63%$92.48$19.28-79.2%
3.6%
IOVAIOVANCE BIOTHERAPEUTICS INC$209.6M3.29%$24.66$4.31-82.5%
3.3%
ARNAARENA PHARMACEUTICALS INC$204.0M3.20%β€”β€”
3.2%
FOLDAMICUS THERAPEUTICS INC$168.8M2.65%β€”β€”
2.6%
APLSAPELLIS PHARMACEUTICALS INC$164.8M2.59%$32.96β€”
2.6%
ALNYALNYLAM PHARMACEUTICALS INC$160.5M2.52%$188.81$312.78+65.7%
2.5%
BMRNBIOMARIN PHARMACEUTICAL INC$144.9M2.28%$77.29$58.99-23.7%
2.3%
VRTXVERTEX PHARMACEUTICALS INC$120.4M1.89%$181.39$528.04+191.1%
1.9%
ISEEIVERIC BIO INC$115.3M1.81%β€”β€”
1.8%
MDGLMADRIGAL PHARMACEUTICALS INC$113.7M1.79%$79.79$528.10+561.9%
1.8%
TRILLIUM THERAPEUTICS INC$100.1M1.57%β€”β€”
1.6%
PMVPPMV PHARMACEUTICALS INC$87.2M1.37%$29.80$1.22-95.9%
1.4%
KURAKURA ONCOLOGY INC$74.9M1.18%$18.73$11.10-40.7%
1.2%
MRSNMERSANA THERAPEUTICS INC$64.1M1.01%β€”β€”
1.0%
GLUEMONTE ROSA THERAPEUTICS INC$61.0M0.96%$22.28$24.21+8.7%
1.0%
XENEXENON PHARMACEUTICALS INC$55.8M0.88%$15.28$60.96+298.9%
0.9%
WHWKAADI BIOSCIENCES INC$53.7M0.84%$29.37$4.19-85.7%
0.8%
MNKDMANNKIND CORP$38.3M0.60%$4.35$4.52+3.9%
0.6%
CBAYCYMABAY THERAPEUTICS INC$37.6M0.59%β€”β€”
0.6%
MRNSMARINUS PHARMACEUTICALS INC$36.8M0.58%β€”β€”
0.6%
ACADACADIA PHARMACEUTICALS INC$36.5M0.57%$16.61$25.97+56.4%
0.6%
DCPHDECIPHERA PHARMACEUTICALS INC$36.3M0.57%β€”β€”
0.6%
AMRNXXXXAMARIN CORP PLC$30.6M0.48%β€”β€”
0.5%
PRAXPRAXIS PRECISION MEDICINES INC$29.6M0.46%$277.35$318.52+14.8%
0.5%

Quarter-on-Quarter Activity

Q3 2021 vs. Q2 2021

New Positions (6)

TickerIssuerNotionalSince Filing
WHWKAADI BIOSCIENCES INC$53.7M-85.7%
KYMRKYMERA THERAPEUTICS INC$26.8M
DICEDICE THERAPEUTICS INC$26.2M
BIIBBIOGEN INC$23.8M
NUVLNUVALENT INC$22.3M
TNGXTANGO THERAPEUTICS INC$20.0M

Exited Positions (7)

TickerIssuerNotional
CNSTCONSTELLATION PHARMACEUTICALS INC$108.5M
RLMDRELMADA THERAPEUTICS INC$29.9M
OLMAOLEMA PHARMACEUTICALS INC$24.5M
CNTACENTESSA PHARMACEUTICALS PLC$11.1M
BCTGBCTG ACQUISITION CORP$9.1M
ADAPYADAPTIMMUNE THERAPEUTICS PLC$8.6M
ARPOAERPIO PHARMACEUTICALS INC$7.6M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
APLSCALLAPELLIS PHARMACEUTICALS INC$161.4M+1983.3%
APLSCALLAPELLIS PHARMACEUTICALS INC$-2.1M+531.2%
ALNYALNYLAM PHARMACEUTICALS INC$159.1M+466.7%+65.7%
APLSCALLAPELLIS PHARMACEUTICALS INC$101.3M+397.4%
RNAMAVIDITY BIOSCIENCES INC$14.9M+111.0%
PMVPPMV PHARMACEUTICALS INC$24.8M+60.3%-95.9%
APLSCALLAPELLIS PHARMACEUTICALS INC$-62.3M+50.7%
FOLDAMICUS THERAPEUTICS INC$48.8M+42.0%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
IOVACALLIOVANCE BIOTHERAPEUTICS INC$-235.2M-92.9%-82.5%
SRPTCALLSAREPTA THERAPEUTICS INC$-184.4M-91.7%-79.2%
XLRNCALLACCELERON PHARMA INC$-376.4M-84.1%
SNDXSYNDAX PHARMACEUTICALS INC$-22.0M-48.5%
AVDLXXXXAVADEL PHARMACEUTICALS PLC$-7.1M-47.9%
MRUSMERUS N V$-4.0M-31.8%
ARNAARENA PHARMACEUTICALS INC$-74.0M-16.0%
VRTXVERTEX PHARMACEUTICALS INC$-38.8M-15.9%+191.1%
← Back to Hedge Funds